Medicus Pharma Ltd. Common Stock
MDCX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,685 | $1,440 | $2,006 | $1,365 |
| G&A Expenses | $0 | $4,577 | $3,120 | $1,064 |
| SG&A Expenses | $5,024 | $4,577 | $3,120 | $1,064 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$78 |
| Operating Expenses | $6,709 | $6,016 | $5,126 | $2,351 |
| Operating Income | -$6,709 | -$6,016 | -$5,126 | -$2,351 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$9,272 | -$160 | $24 | $76 |
| Pre-Tax Income | -$15,981 | -$6,176 | -$5,102 | -$2,275 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15,981 | -$6,176 | -$5,102 | -$2,275 |
| % Margin | – | – | – | – |
| EPS | -1.12 | -0.43 | -0.42 | -0.239 |
| % Growth | -160.5% | -2.4% | -75.7% | – |
| EPS Diluted | -1.12 | -0.43 | -0.42 | -0.239 |
| Weighted Avg Shares Out | 18,632 | 14,284 | 12,240 | 9,515 |
| Weighted Avg Shares Out Dil | 18,632 | 14,284 | 12,240 | 9,515 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $40 | $24 | $49 |
| Interest Expense | – | $0 | $0 | $796 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$15,981 | -$6,016 | -$5,102 | -$1,478 |
| % Margin | – | – | – | – |